A person starting dialysis in the United States lives, on average, roughly two and a half to three years from the start of treatment, though that number obscures enormous variation. A healthy 30-year-old beginning dialysis can survive for decades; a frail 85-year-old with multiple chronic conditions may not make it a year. Age, the underlying cause of kidney failure, the type of dialysis, and even where you live all bend that average dramatically in one direction or the other. The question is less about a single number and more about understanding which factors push survival up or down for a given person.
What the Average Numbers Actually Look Like
The most commonly cited figure comes from US Renal Data System analyses, which found that the average new dialysis patient could expect to live about 31 months. For context, that places dialysis patients’ survival roughly between that of someone newly diagnosed with colon cancer and someone diagnosed with lung cancer. For patients over 45, life expectancy is approximately a quarter of what it would be for someone the same age in the general population.1Journal of the American Society of Nephrology. Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications
Those numbers have improved modestly over the decades, but not as much as you might hope. Between 1977 and 2007, life expectancy for a 50-year-old on dialysis rose from about 7.3 years to 7.9 years. That sounds like progress, but over the same period, a 50-year-old in the general population gained more than three additional years of life. So the gap between dialysis patients and everyone else actually widened.2American Journal of Kidney Diseases. Survival Trends in ESRD Patients Compared With the General Population in the United States More recent data show that mortality on hemodialysis has been declining since the late 1990s, driven by evolving treatment practices across different regions.3American Journal of Kidney Diseases. Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Still, dialysis survival lags far behind normal life expectancy, and the improvement has been gradual rather than dramatic.
Age and Frailty Are the Biggest Predictors
Nothing predicts dialysis survival more powerfully than how old and how sick you are when you start. A study of older adults initiating dialysis found that being 85 or older nearly doubled the risk of dying within the first year. Having trouble with basic daily activities like bathing or dressing raised the risk by a similar amount. Starting dialysis as an inpatient, which often means the decision was made during a medical crisis rather than planned in advance, more than doubled first-year mortality. And carrying four or more chronic conditions on top of kidney failure boosted the death risk by about 50%.4JAMA Internal Medicine. One-Year Mortality After Dialysis Initiation Among Older Adults
Younger, relatively healthy patients paint a completely different picture. Some people remain on dialysis for 20 or even 30 years. These tend to be people who started dialysis at a younger age, have few other health problems, adhere closely to their treatment schedule and dietary requirements, and have good vascular access for hemodialysis. But they are the exception. The averages are pulled down heavily by the large number of older, sicker patients who now make up the majority of the dialysis population.
Why Diabetes Changes the Equation
The cause of your kidney failure matters, and diabetes is the single most important dividing line. Diabetes is the leading cause of kidney failure requiring dialysis, and patients whose kidneys failed because of diabetes have substantially worse outcomes than those whose kidneys failed for other reasons. One study found that diabetic dialysis patients had roughly 80% higher mortality than non-diabetic patients, even after adjusting for differences in age, blood pressure, smoking, and cardiovascular history.5PubMed Central. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition The primary reason is cardiovascular disease. Diabetes damages blood vessels throughout the body, and the combination of diabetes and kidney failure accelerates heart disease and stroke at an alarming rate.6Diabetes Research and Clinical Practice. Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience
An interesting wrinkle: it does not seem to matter much whether diabetes caused the kidney failure directly or was simply present as an additional condition. Patients with diabetes as a co-existing problem had a similarly elevated mortality risk compared to those without diabetes at all.5PubMed Central. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition In other words, diabetes is dangerous for dialysis patients regardless of what actually destroyed their kidneys.
Hemodialysis Versus Peritoneal Dialysis
Patients and families often want to know whether one type of dialysis leads to longer survival. The answer is frustratingly conditional. Peritoneal dialysis, where fluid is cycled through the abdomen to filter waste, appeared to offer a significant early advantage in one analysis that found roughly 48% lower mortality than hemodialysis over the first two years of treatment.7PubMed Central. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis But much of that advantage may reflect patient selection. When researchers looked specifically at patients who were genuinely eligible for either modality, survival was similar regardless of age.8American Journal of Kidney Diseases. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities
For older adults, the picture tilts the other way. A meta-analysis of older dialysis patients found that peritoneal dialysis carried about 17% higher mortality than hemodialysis, with the gap widening in patients who had diabetes, multiple comorbidities, or who had been on dialysis for more than three years.9PubMed Central. Mortality of Peritoneal Dialysis versus Hemodialysis in Older Adults: An Updated Systematic Review and Meta-Analysis Part of the problem is that the peritoneal membrane itself degrades over years of use. Scarring and structural changes reduce the membrane’s filtering capacity, and in severe cases this can lead to a dangerous condition called encapsulating peritoneal sclerosis, where scar tissue wraps around the bowel.10Frontiers in Physiology. Aging of the Peritoneal Dialysis Membrane This effectively puts a ceiling on how many years peritoneal dialysis can be sustained for some patients.
The practical takeaway is that neither modality is categorically superior. Younger, healthier patients often do well with peritoneal dialysis and benefit from the independence it offers. Older patients with diabetes or multiple health problems may fare better with hemodialysis, especially over the long term. The choice usually involves balancing survival data against lifestyle preferences and the ability to manage treatment at home.
What Actually Kills Dialysis Patients
Cardiovascular disease is the leading killer. One large study of patients starting dialysis found that about 39% died from cardiovascular causes, while 51% died from non-cardiovascular causes, including infections at about 15% and cancers at about 8%.11JAMA. Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis A study from a Chinese hemodialysis population found cardiovascular disease responsible for about 30% of deaths, followed by cerebrovascular disease at nearly 20% and infections at about 17%.12PubMed Central. Research Study on causes of death and influencing factors in hemodialysis patients with End-Stage renal disease
The cardiovascular risk is not just from the underlying kidney disease. Hemodialysis itself stresses the heart. Each session involves rapid shifts in fluid volume and blood pressure, which can temporarily stun the heart muscle by reducing blood flow to parts of it. Repeated over hundreds of sessions, this process can lead to chronic damage and declining heart function.13PubMed Central. Hemodialysis-induced cardiac injury: determinants and associated outcomes It is a cruel irony: the treatment keeping you alive gradually contributes to the cardiovascular disease most likely to kill you.
One older but striking analysis found that infection, not heart disease, was the leading cause of death in its dialysis population, accounting for more than 36% of all deaths. That same study noted that withdrawal from dialysis was the cause of death in about 21% of patients, most commonly among those over 61.14PubMed. Mortality in dialysis patients: analysis of the causes of death Voluntary withdrawal is an underappreciated reality. After years of treatment, some patients decide the burden outweighs the benefit.
How Your Vascular Access Affects Survival
For hemodialysis patients, the connection point where blood is drawn out and returned, called vascular access, has a surprisingly large effect on how long you live. The gold standard is an arteriovenous fistula, a surgically created connection between an artery and a vein, usually in the arm. This is preferred because it lasts longer, gets fewer infections, and is associated with the best survival outcomes.15PubMed. Survival and complications of arteriovenous fistula dialysis access in an elderly population
The alternative is a central venous catheter, a tube inserted into a large vein in the neck or chest. These are often necessary when dialysis needs to start urgently before a fistula can be created and mature. But the mortality difference is stark. One seven-year cohort study found that patients using a tunneled catheter had about 2.8 times the risk of dying compared to those with a fistula, and those with a non-tunneled catheter faced a five-fold increase in death risk.16PubMed Central. Vascular Access Type and Survival Outcomes in Hemodialysis Patients: A Seven-Year Cohort Study Much of this excess risk comes from bloodstream infections and clotting complications. Getting a fistula placed early, ideally before dialysis even begins, is one of the single most impactful things a patient can do for long-term survival.
Can More Frequent Dialysis Help You Live Longer?
Conventional hemodialysis is typically done three times per week, for about four hours per session. Nocturnal hemodialysis, performed overnight for six to eight hours several nights a week, aims to more closely mimic the continuous filtering that healthy kidneys provide. The idea makes intuitive sense: more dialysis should mean better waste removal and less cardiovascular stress.
The clinical evidence is mixed. A randomized trial of nightly hemodialysis six times per week versus conventional three-times-weekly treatment found that the more frequent schedule significantly reduced left ventricular mass (a marker of heart strain), improved blood pressure, and allowed most patients to reduce or stop blood pressure medications and phosphate binders.17JAMA. Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial These are real physiological improvements. Yet a separate trial from the Frequent Hemodialysis Network failed to show a mortality benefit for nocturnal dialysis, and its long-term follow-up actually found higher mortality in the nocturnal group, though the study was small and underpowered.18American Journal of Kidney Diseases. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial
Registry-based observational data paint a more optimistic picture, with several analyses showing a 25–65% reduction in mortality risk for nocturnal hemodialysis patients. But these studies suffer from selection bias: patients who choose and tolerate more intensive dialysis tend to be healthier and more motivated to begin with.19PubMed Central. Nocturnal hemodialysis: improved quality of life and patient outcomes So while more frequent dialysis clearly improves intermediate health markers, whether it truly extends life remains an open question.
Transplant Versus Staying on Dialysis
For patients who are eligible, a kidney transplant offers substantially better survival than remaining on dialysis. An analysis using a trial-emulation design found that transplant recipients gained about half a year of additional life over five years of follow-up, and about 2.4 additional years over ten years, compared to patients who stayed on the transplant waiting list receiving dialysis.20JAMA Network Open. Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure The benefit held across age groups, and other analyses confirm gains of roughly 1.9 to 2.4 additional life years for transplant-listed patients of various ages and comorbidity profiles.21PLOS ONE. Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
But transplant is not available to everyone. Only a fraction of dialysis patients are healthy enough to undergo major surgery and tolerate immunosuppressive drugs. The waiting list for deceased-donor kidneys often stretches to five years or more in many parts of the country. Living-donor transplants offer a faster path, but finding a compatible willing donor is its own challenge. For the majority of dialysis patients, the treatment they start on is the treatment they remain on.
When Dialysis May Not Be Worth Starting
This is perhaps the hardest conversation in nephrology. For very old or very frail patients, dialysis does not always extend life in a meaningful way. A systematic review and meta-analysis found that overall, dialysis roughly halves the risk of death compared to conservative care, which involves managing symptoms and slowing kidney decline without dialysis. But that benefit shrank considerably in patients with severe comorbidity or advanced age.22PubMed Central. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis
A longitudinal study of elderly patients found that in those over 80, there was no detectable survival advantage for dialysis compared to conservative management. Meanwhile, half of the dialysis patients were hospitalized within six months of starting, compared to about a quarter of those on conservative care. Quality of life did not improve for the dialysis group but declined measurably for the conservative group over the same period.23PubMed Central. Quality of life after the initiation of dialysis or maximal conservative management in elderly patients Reviews of the broader literature confirm that dialysis prolongs survival mainly in younger and less frail patients, while conservative kidney management provides comparable or even better quality of life and fewer hospitalizations in the most vulnerable groups.24PubMed Central. Dialysis versus conservative kidney management in older adults: why one size does not fit all
This does not mean dialysis is pointless for older adults. Many people in their 70s and 80s do well and gain meaningful years. The evidence suggests that the benefit fades most for those who are already deeply frail, dependent on others for daily activities, and living with multiple serious illnesses. For these patients, the burdens of thrice-weekly treatment, dietary restrictions, and frequent hospitalization may outweigh whatever survival advantage dialysis provides.
The Slow Toll of Long-Term Dialysis
Patients who survive many years on dialysis face complications that accumulate with time. One well-recognized condition is dialysis-related amyloidosis, where a protein that healthy kidneys normally filter out builds up and forms deposits in joints and bones. The result is carpal tunnel syndrome, chronic joint pain, bone cysts, and progressive damage to the spine.25PubMed Central. Dialysis-related amyloidosis: challenges and solutions Risk factors include the duration of dialysis treatment and the type of dialysis membrane used, with older low-flux membranes carrying a higher risk.26Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics. Historical background and clinical treatment of dialysis-related amyloidosis Modern high-flux membranes have reduced but not eliminated this problem.
Beyond amyloidosis, physical quality of life tends to decline over time while mental health remains more stable. A Dutch study following dialysis patients found that physical quality of life scores dropped over the course of treatment, though mental health scores held relatively steady.27Kidney International. Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis A separate two-year follow-up of patients already established on dialysis found no significant change in physical activity levels, physical function, or quality-of-life summary scores, suggesting that after an initial adjustment period, many patients reach a plateau rather than continuing to decline steeply.28Nephron. The Effects of Chronic Dialysis on Physical Status, Quality of Life, and Arterial Stiffness: A Longitudinal Study in Prevalent Dialysis Patients
Depression, Diet, and the Hidden Drivers of Survival
Technical factors like dialysis dose and vascular access get the most attention, but psychological health and nutritional status quietly shape outcomes in ways that are easy to overlook. Depression is common among dialysis patients, and it has a direct impact on survival through its effect on treatment adherence. Research shows that every incremental increase in depressive symptoms predicts a higher risk of not following fluid and dietary restrictions, which are critical for managing the buildup of toxins and fluid between sessions.29PubMed Central. Depressive Symptoms and Dietary Adherence in Patients with End-Stage Renal Disease Systematic reviews confirm that depressive symptoms are linked to worse quality of life and increased mortality in this population.30PubMed Central. Depressive symptoms and dietary non-adherence among end stage renal disease patients undergoing hemodialysis therapy: systematic review
Nutritional status is another underappreciated factor. Protein-energy wasting, a form of malnutrition common in dialysis patients, combines with the chronic inflammation that kidney failure produces and the cardiovascular disease that nearly all these patients carry. This triad of malnutrition, inflammation, and cardiovascular disease interacts to drive mortality in a way that is greater than the sum of its parts.31Nephrology Dialysis Transplantation. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients Adequate nutrition, treating depression, and maintaining social support are not glamorous interventions, but they can genuinely affect how long someone survives on dialysis.
Socioeconomic and Geographic Disparities
Where you live and what resources you have access to also matter. A meta-analysis of socioeconomic factors found that lower income was associated with higher mortality in both hemodialysis and peritoneal dialysis patients, with the effect being more pronounced for peritoneal dialysis. Lower education and occupational status showed similar patterns.32PubMed. Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis These disparities are likely driven by differences in access to care, nutrition, transportation to dialysis centers, and the ability to manage the complex demands of a dialysis regimen.
Race and neighborhood interact in troubling ways. Among young adult dialysis patients in the United States, Black patients living in low-income neighborhoods had higher mortality than White patients in the same neighborhoods, even after accounting for clinical differences and access to care. That racial gap in survival shrank in higher-income neighborhoods, suggesting that socioeconomic context amplifies or dampens the effects of race on dialysis outcomes.33PubMed Central. Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients Dialysis survival is not just a medical question. It is shaped by the same social forces that drive health disparities across every area of medicine.